Biodesix Insider Schuler Buys 13,900 Shares Amid 52‑Week High, Signals Long‑Term Confidence for Investors
Insider buying by Jack W Schuler at Biodesix signals confidence in its lung‑cancer diagnostics pipeline, suggesting a potential buying opportunity for investors.
4 minutes to read